Supporting smoking cessation

Nicholas A. Zwar, Colin P. Mendelsohn, Robyn L. Richmond

Research output: Contribution to journalArticleResearchpeer-review

32 Citations (Scopus)

Abstract

Summary points
- Throughout the world tobacco smoking is the leading cause of preventable death and illness
- As smoking rates in the general population fall in developed countries, a greater proportion of smokers have coexisting problems such as mental illness
- Cessation support from doctors and other health professionals increases quit rates
- Tobacco dependence is most effectively treated with a comprehensive approach involving behavioural support and pharmacotherapy
- Effective medicines include nicotine replacement therapy, varenicline, bupropion, nortriptyline, and cytisine. The availability and registration of these medicines varies between countries
Original languageEnglish
Article numberf7535
JournalBMJ (Online)
Volume348
DOIs
Publication statusPublished - 14 Jan 2014
Externally publishedYes

Fingerprint

Smoking Cessation
Smoking
Nortriptyline
Bupropion
Tobacco Use Disorder
Nicotine
Developed Countries
Cause of Death
Drug Therapy
Health
Population
Therapeutics
Varenicline
cytisine

Cite this

Zwar, N. A., Mendelsohn, C. P., & Richmond, R. L. (2014). Supporting smoking cessation. BMJ (Online), 348, [f7535]. https://doi.org/10.1136/bmj.f7535
Zwar, Nicholas A. ; Mendelsohn, Colin P. ; Richmond, Robyn L. / Supporting smoking cessation. In: BMJ (Online). 2014 ; Vol. 348.
@article{630ca41ce3c7480995c809e3363fb693,
title = "Supporting smoking cessation",
abstract = "Summary points- Throughout the world tobacco smoking is the leading cause of preventable death and illness- As smoking rates in the general population fall in developed countries, a greater proportion of smokers have coexisting problems such as mental illness- Cessation support from doctors and other health professionals increases quit rates- Tobacco dependence is most effectively treated with a comprehensive approach involving behavioural support and pharmacotherapy- Effective medicines include nicotine replacement therapy, varenicline, bupropion, nortriptyline, and cytisine. The availability and registration of these medicines varies between countries",
author = "Zwar, {Nicholas A.} and Mendelsohn, {Colin P.} and Richmond, {Robyn L.}",
year = "2014",
month = "1",
day = "14",
doi = "10.1136/bmj.f7535",
language = "English",
volume = "348",
journal = "BMJ (Clinical research ed.)",
issn = "0959-535X",
publisher = "BMJ Publishing Group",

}

Zwar, NA, Mendelsohn, CP & Richmond, RL 2014, 'Supporting smoking cessation' BMJ (Online), vol. 348, f7535. https://doi.org/10.1136/bmj.f7535

Supporting smoking cessation. / Zwar, Nicholas A.; Mendelsohn, Colin P.; Richmond, Robyn L.

In: BMJ (Online), Vol. 348, f7535, 14.01.2014.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Supporting smoking cessation

AU - Zwar, Nicholas A.

AU - Mendelsohn, Colin P.

AU - Richmond, Robyn L.

PY - 2014/1/14

Y1 - 2014/1/14

N2 - Summary points- Throughout the world tobacco smoking is the leading cause of preventable death and illness- As smoking rates in the general population fall in developed countries, a greater proportion of smokers have coexisting problems such as mental illness- Cessation support from doctors and other health professionals increases quit rates- Tobacco dependence is most effectively treated with a comprehensive approach involving behavioural support and pharmacotherapy- Effective medicines include nicotine replacement therapy, varenicline, bupropion, nortriptyline, and cytisine. The availability and registration of these medicines varies between countries

AB - Summary points- Throughout the world tobacco smoking is the leading cause of preventable death and illness- As smoking rates in the general population fall in developed countries, a greater proportion of smokers have coexisting problems such as mental illness- Cessation support from doctors and other health professionals increases quit rates- Tobacco dependence is most effectively treated with a comprehensive approach involving behavioural support and pharmacotherapy- Effective medicines include nicotine replacement therapy, varenicline, bupropion, nortriptyline, and cytisine. The availability and registration of these medicines varies between countries

UR - http://www.scopus.com/inward/record.url?scp=84892774992&partnerID=8YFLogxK

U2 - 10.1136/bmj.f7535

DO - 10.1136/bmj.f7535

M3 - Article

VL - 348

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

SN - 0959-535X

M1 - f7535

ER -

Zwar NA, Mendelsohn CP, Richmond RL. Supporting smoking cessation. BMJ (Online). 2014 Jan 14;348. f7535. https://doi.org/10.1136/bmj.f7535